XML 15 R4.htm IDEA: XBRL DOCUMENT v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Selling, general and administrative $ 2,990 $ 1,933 $ 9,884 $ 8,316
Research and development 1,515 597 6,488 2,485
Change in fair value of contingent consideration (22) (37) (36) (3,509)
Total operating costs and expenses 4,483 2,493 16,336 7,292
Loss from operations (4,483) (2,493) (16,336) (7,292)
Other (loss) income:        
Change in fair value of convertible notes (214) (1,877) (9,154) (5,362)
Change in fair value of warrants 7,014 (236) 16,611 85,950
Loss on issuance of warrants       (75,644)
Loss on extinguishment of debt     (76)  
Loss on derivative liability     (1,743)  
Other income, net 148 68 215 263
Total other income (loss), net 6,948 (2,045) 5,853 5,207
Income (loss) before taxes 2,465 (4,538) (10,483) (2,085)
Net income (loss) $ 2,465 $ (4,538) $ (10,483) $ (2,085)
Basic net income (loss) per share attributable to common stockholders (in dollars per share) $ 0.01 $ (0.39) $ (0.17) $ (0.23)
Diluted net income (loss) per share attributable to common stockholders (in dollars per share) $ 0.01 $ (0.39) $ (0.17) $ (0.23)
Weighted average shares of common stock outstanding used to compute basic net income (loss) per share (in shares) 89,957,587 11,634,946 60,548,285 8,931,566
Weighted average shares of common stock outstanding used to compute diluted net income (loss) per share (in shares) 89,957,587 11,634,946 60,548,285 8,931,566